Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century-Reference-Cited by-同舟云学术

Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century

Published:2014-01-16 Issue:6 Volume:164 Page:851-857
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Pulte Dianne¹²,Jansen Lina¹,Gondos Adam¹,Emrich Katharina³,Holleczek Bernd⁴,Katalinic Alexander⁵,Brenner Hermann¹,

Affiliation:

1. Division of Clinical Epidemiology and Aging Research; German Cancer Research Centre; Heidelberg Germany

2. Division of Hematology; Department of Medicine; Thomas Jefferson University; Philadelphia PA USA

3. Cancer Registry of Rhineland-Palatinate Institute for Medical Biostatistics; Epidemiology and Informatics; University Medical Centre; Johannes Gutenberg University Mainz; Mainz Germany

4. Saarland Cancer Registry; Saarbrücken Germany

5. Cancer Registry of Schleswig-Holstein; Lübeck Germany

Funder

German Cancer Aid

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12722/fullpdf

Reference32 articles.

1. United States life tables, 2000;Arias;National Vital Statistics Reports,2002

2. Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease;Armitage;American Journal of Medicine,1991

3. Twenty-five years clinical trials of the german hodgkin study group (GHSG);Behringer;European Journal of Haematology. Supplementum,2005

4. An alternative approach to monitoring cancer patient survival;Brenner;Cancer,1996

5. Up-to-date long-term survival curves of patients with cancer by period analysis;Brenner;Journal of Clinical Oncology,2002

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Profile and Outcome of Adult Classical Hodgkin’s Lymphoma: Real World Single Centre Experience;Indian Journal of Hematology and Blood Transfusion;2024-02-09

2. Expanding the armory for treating lymphoma: Targeting redox cellular status through thioredoxin reductase inhibition;Pharmacological Research;2022-03

3. Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years;eJHaem;2021-05-06

4. Outcome of elderly patients with classical Hodgkin’s lymphoma;Leukemia Research;2020-03

5. Hodgkin’s Lymphoma;Fertility Preservation in Oncological and Non-Oncological Diseases;2020